Kitea Health Opens New Facility to Advance Brain Care

Kitea Health has announced the opening of its new state-of-the-art facility, marking a significant milestone in its commitment to innovation, quality care, and improving the way chronic care is managed.

Designed with a strong focus on safety and reliability, the facility operates under ISO 13485 and GMP standards. It has the capacity to produce up to 10,000 Kitea Systems annually, supporting chronic care management while also contributing to the local economy. The company’s micro implantable brain device, the first of its kind in New Zealand and the first in the world, will now be delivered to patients with even greater consistency and quality through this new production space.

Beyond manufacturing, the facility serves as a collaborative hub, bringing together healthcare professionals and research partners. It is intended to foster innovation, encourage the exchange of ideas, and drive advancements in brain care.

Kitea Health has expressed its gratitude to its team, partners, and supporters who helped make the facility possible. From this new base, the company looks ahead to continuing its mission to improve health management and enhance patient well-being on a global scale.